Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Crazy About AtriCure Inc. (ATRC)

Hedge fund managers like David Einhorn, Dan Loeb, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks may provide us with significant returns as well. Many hedge funds, like Paul Singer’s Elliott Management, are pretty secretive, but we can still get some insights by analyzing their quarterly 13F filings. One of the most fertile grounds for large abnormal returns is hedge funds’ most popular small-cap picks, which are not so widely followed and often trade at a discount to their intrinsic value. In this article we will check out hedge fund activity in another small-cap stock: AtriCure Inc. (NASDAQ:ATRC).

Is AtriCure Inc. (NASDAQ:ATRC) a healthy stock for your portfolio? The best stock pickers are taking a bullish view. The number of long hedge fund bets advanced by 4 in recent months. Our calculations also showed that ATRC isn’t among the 30 most popular stocks among hedge funds.

Today there are dozens of methods shareholders employ to assess stocks. Two of the most under-the-radar methods are hedge fund and insider trading signals. We have shown that, historically, those who follow the best picks of the top money managers can outpace the broader indices by a significant margin (see the details here).

MILLENNIUM MANAGEMENT

We’re going to take a gander at the key hedge fund action regarding AtriCure Inc. (NASDAQ:ATRC).

How have hedgies been trading AtriCure Inc. (NASDAQ:ATRC)?

Heading into the fourth quarter of 2018, a total of 22 of the hedge funds tracked by Insider Monkey were long this stock, a change of 22% from the previous quarter. On the other hand, there were a total of 18 hedge funds with a bullish position in ATRC at the beginning of this year. With hedge funds’ sentiment swirling, there exists a select group of key hedge fund managers who were increasing their stakes substantially (or already accumulated large positions).

ATRC_dec2018

Among these funds, Hudson Executive Capital held the most valuable stake in AtriCure Inc. (NASDAQ:ATRC), which was worth $83.2 million at the end of the third quarter. On the second spot was Millennium Management which amassed $23.5 million worth of shares. Moreover, Royce & Associates, DAFNA Capital Management, and Tamarack Capital Management were also bullish on AtriCure Inc. (NASDAQ:ATRC), allocating a large percentage of their portfolios to this stock.

As aggregate interest increased, key hedge funds were breaking ground themselves. Sectoral Asset Management, managed by Jerome Pfund and Michael Sjostrom, established the most valuable position in AtriCure Inc. (NASDAQ:ATRC). Sectoral Asset Management had $8.8 million invested in the company at the end of the quarter. Steve Cohen’s Point72 Asset Management also made a $6.1 million investment in the stock during the quarter. The following funds were also among the new ATRC investors: Efrem Kamen’s Pura Vida Investments, Matthew Hulsizer’s PEAK6 Capital Management, and Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital.

Let’s go over hedge fund activity in other stocks similar to AtriCure Inc. (NASDAQ:ATRC). These stocks are AVROBIO, Inc. (NASDAQ:AVRO), Geopark Ltd (NYSE:GPRK), Hess Midstream Partners LP (NYSE:HESM), and iShares MSCI Europe Financials ETF (NASDAQ:EUFN). All of these stocks’ market caps resemble ATRC’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
AVRO 14 249988 -5
GPRK 10 84765 -1
HESM 6 9071 1
EUFN 2 86190 0
Average 8 107504 -1.25

View table here if you experience formatting issues.

As you can see these stocks had an average of 8 hedge funds with bullish positions and the average amount invested in these stocks was $108 million. That figure was $189 million in ATRC’s case. AVROBIO, Inc. (NASDAQ:AVRO) is the most popular stock in this table. On the other hand iShares MSCI Europe Financials ETF (NASDAQ:EUFN) is the least popular one with only 2 bullish hedge fund positions. Compared to these stocks AtriCure Inc. (NASDAQ:ATRC) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.